| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

As shown in table 2, both OS and CBR values were in line or higher than those reported in the treatment arm of the ASCENT ...

For more information about Syncromune, please visit www.syncromune.com.

A pre-surgical combination therapy including pembrolizumab plus dabrafenib and trametinib (DTP) significantly improved ...

The findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...

Auron Therapeutics begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Monday, June 2, 2025, 16:00 Hrs [IST] Auron Thera ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

The oral presentation at the 2025 ASCO Annual Meeting (Abstract 4003) was titled "Claudin18.2-specific CAR T cells (Satri-cel ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary ...

Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...

The mortar had ripped through the hall’s canvas roof and sprayed shrapnel in every direction. Compared to others, Turner was ...